What is the projected market valuation of the Plant Genotyping Equipment Market by 2035?

The projected market valuation for the Plant Genotyping Equipment Market is 4.597 USD Billion by 2035. Read More

What was the market valuation of the Plant Genotyping Equipment Market in 2024?

The overall market valuation was 2.181 USD Billion in 2024. Read More

What is the expected CAGR for the Plant Genotyping Equipment Market during the forecast period 2025 - 2035?

The expected CAGR for the Plant Genotyping Equipment Market during the forecast period 2025 - 2035 is 7.01%. Read More

Which companies are considered key players in the Plant Genotyping Equipment Market?

Key players in the market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Qiagen, LGC Limited, Eurofins Scientific, Genomatix Software, and PerkinElmer. Read More

What are the main segments of the Plant Genotyping Equipment Market?

The main segments include Genotyping Technology, Testing Method, End User, Application Area, and Equipment Type. Read More

What was the valuation of SNP Genotyping in 2024?

The valuation of SNP Genotyping was 0.654 USD Billion in 2024. Read More

What is the projected valuation for Non-Destructive Testing by 2035?

The projected valuation for Non-Destructive Testing is 3.205 USD Billion by 2035. Read More

How much is the market for Agricultural Biotechnology Companies expected to grow by 2035?

The market for Agricultural Biotechnology Companies is expected to grow to 1.845 USD Billion by 2035. Read More

What is the valuation of PCR Machines in 2024?

The valuation of PCR Machines was 0.654 USD Billion in 2024. Read More

Plant Genotyping Equipment Market

Q: What applications are driving growth in the Plant Genotyping Equipment Market?

Applications driving growth include Plant Breeding, Disease Resistance, Genetic Diversity Analysis, and Crop Improvement. Read More

ID: MRFR/HC/39474-HCR

111 Pages

Satyendra Maurya

Last Updated: April 06, 2026

Plant Genotyping Equipment Market Research Report: By Genotyping Technology (SNP Genotyping, SSR Genotyping, Next-Generation Sequencing, DNA Microarrays), By Destructive vs. Non-Destructive Testing (Destructive Testing, Non-Destructive Testing), By End User (Research Institutions, Agricultural Biotechnology Companies, Government Agencies), By Application Area (Plant Breeding, Disease Resistance, Genetic Diversity Analysis, Crop Improvement), By Equipment Type (PCR Machines, Electrophoresis Equipment, Sequencing Systems, Sample Preparation Equipment) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Plant Genotyping Equipment Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Chemicals and Materials, BY Genotyping Technology (USD Billion)
4.1.1 SNP Genotyping
4.1.2 SSR Genotyping
4.1.3 Next-Generation Sequencing
4.1.4 DNA Microarrays
4.2 Chemicals and Materials, BY Testing Method (USD Billion)
4.2.1 Destructive Testing
4.2.2 Non-Destructive Testing
4.3 Chemicals and Materials, BY End User (USD Billion)
4.3.1 Research Institutions
4.3.2 Agricultural Biotechnology Companies
4.3.3 Government Agencies
4.4 Chemicals and Materials, BY Application Area (USD Billion)
4.4.1 Plant Breeding
4.4.2 Disease Resistance
4.4.3 Genetic Diversity Analysis
4.4.4 Crop Improvement
4.5 Chemicals and Materials, BY Equipment Type (USD Billion)
4.5.1 PCR Machines
4.5.2 Electrophoresis Equipment
4.5.3 Sequencing Systems
4.5.4 Sample Preparation Equipment
4.6 Chemicals and Materials, BY Region (USD Billion)
4.6.1 North America
4.6.1.1 US
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 UK
4.6.2.3 France
4.6.2.4 Russia
4.6.2.5 Italy
4.6.2.6 Spain
4.6.2.7 Rest of Europe
4.6.3 APAC
4.6.3.1 China
4.6.3.2 India
4.6.3.3 Japan
4.6.3.4 South Korea
4.6.3.5 Malaysia
4.6.3.6 Thailand
4.6.3.7 Indonesia
4.6.3.8 Rest of APAC
4.6.4 South America
4.6.4.1 Brazil
4.6.4.2 Mexico
4.6.4.3 Argentina
4.6.4.4 Rest of South America
4.6.5 MEA
4.6.5.1 GCC Countries
4.6.5.2 South Africa
4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Chemicals and Materials
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 Illumina (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Thermo Fisher Scientific (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Agilent Technologies (US)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Bio-Rad Laboratories (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Qiagen (DE)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 LGC Limited (GB)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Eurofins Scientific (LU)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Genomatix Software (DE)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 PerkinElmer (US)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.4 US MARKET ANALYSIS BY TESTING METHOD
6.5 US MARKET ANALYSIS BY END USER
6.6 US MARKET ANALYSIS BY APPLICATION AREA
6.7 US MARKET ANALYSIS BY EQUIPMENT TYPE
6.8 CANADA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.9 CANADA MARKET ANALYSIS BY TESTING METHOD
6.10 CANADA MARKET ANALYSIS BY END USER
6.11 CANADA MARKET ANALYSIS BY APPLICATION AREA
6.12 CANADA MARKET ANALYSIS BY EQUIPMENT TYPE
6.13 EUROPE MARKET ANALYSIS
6.14 GERMANY MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.15 GERMANY MARKET ANALYSIS BY TESTING METHOD
6.16 GERMANY MARKET ANALYSIS BY END USER
6.17 GERMANY MARKET ANALYSIS BY APPLICATION AREA
6.18 GERMANY MARKET ANALYSIS BY EQUIPMENT TYPE
6.19 UK MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.20 UK MARKET ANALYSIS BY TESTING METHOD
6.21 UK MARKET ANALYSIS BY END USER
6.22 UK MARKET ANALYSIS BY APPLICATION AREA
6.23 UK MARKET ANALYSIS BY EQUIPMENT TYPE
6.24 FRANCE MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.25 FRANCE MARKET ANALYSIS BY TESTING METHOD
6.26 FRANCE MARKET ANALYSIS BY END USER
6.27 FRANCE MARKET ANALYSIS BY APPLICATION AREA
6.28 FRANCE MARKET ANALYSIS BY EQUIPMENT TYPE
6.29 RUSSIA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.30 RUSSIA MARKET ANALYSIS BY TESTING METHOD
6.31 RUSSIA MARKET ANALYSIS BY END USER
6.32 RUSSIA MARKET ANALYSIS BY APPLICATION AREA
6.33 RUSSIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.34 ITALY MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.35 ITALY MARKET ANALYSIS BY TESTING METHOD
6.36 ITALY MARKET ANALYSIS BY END USER
6.37 ITALY MARKET ANALYSIS BY APPLICATION AREA
6.38 ITALY MARKET ANALYSIS BY EQUIPMENT TYPE
6.39 SPAIN MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.40 SPAIN MARKET ANALYSIS BY TESTING METHOD
6.41 SPAIN MARKET ANALYSIS BY END USER
6.42 SPAIN MARKET ANALYSIS BY APPLICATION AREA
6.43 SPAIN MARKET ANALYSIS BY EQUIPMENT TYPE
6.44 REST OF EUROPE MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.45 REST OF EUROPE MARKET ANALYSIS BY TESTING METHOD
6.46 REST OF EUROPE MARKET ANALYSIS BY END USER
6.47 REST OF EUROPE MARKET ANALYSIS BY APPLICATION AREA
6.48 REST OF EUROPE MARKET ANALYSIS BY EQUIPMENT TYPE
6.49 APAC MARKET ANALYSIS
6.50 CHINA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.51 CHINA MARKET ANALYSIS BY TESTING METHOD
6.52 CHINA MARKET ANALYSIS BY END USER
6.53 CHINA MARKET ANALYSIS BY APPLICATION AREA
6.54 CHINA MARKET ANALYSIS BY EQUIPMENT TYPE
6.55 INDIA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.56 INDIA MARKET ANALYSIS BY TESTING METHOD
6.57 INDIA MARKET ANALYSIS BY END USER
6.58 INDIA MARKET ANALYSIS BY APPLICATION AREA
6.59 INDIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.60 JAPAN MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.61 JAPAN MARKET ANALYSIS BY TESTING METHOD
6.62 JAPAN MARKET ANALYSIS BY END USER
6.63 JAPAN MARKET ANALYSIS BY APPLICATION AREA
6.64 JAPAN MARKET ANALYSIS BY EQUIPMENT TYPE
6.65 SOUTH KOREA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.66 SOUTH KOREA MARKET ANALYSIS BY TESTING METHOD
6.67 SOUTH KOREA MARKET ANALYSIS BY END USER
6.68 SOUTH KOREA MARKET ANALYSIS BY APPLICATION AREA
6.69 SOUTH KOREA MARKET ANALYSIS BY EQUIPMENT TYPE
6.70 MALAYSIA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.71 MALAYSIA MARKET ANALYSIS BY TESTING METHOD
6.72 MALAYSIA MARKET ANALYSIS BY END USER
6.73 MALAYSIA MARKET ANALYSIS BY APPLICATION AREA
6.74 MALAYSIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.75 THAILAND MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.76 THAILAND MARKET ANALYSIS BY TESTING METHOD
6.77 THAILAND MARKET ANALYSIS BY END USER
6.78 THAILAND MARKET ANALYSIS BY APPLICATION AREA
6.79 THAILAND MARKET ANALYSIS BY EQUIPMENT TYPE
6.80 INDONESIA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.81 INDONESIA MARKET ANALYSIS BY TESTING METHOD
6.82 INDONESIA MARKET ANALYSIS BY END USER
6.83 INDONESIA MARKET ANALYSIS BY APPLICATION AREA
6.84 INDONESIA MARKET ANALYSIS BY EQUIPMENT TYPE
6.85 REST OF APAC MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.86 REST OF APAC MARKET ANALYSIS BY TESTING METHOD
6.87 REST OF APAC MARKET ANALYSIS BY END USER
6.88 REST OF APAC MARKET ANALYSIS BY APPLICATION AREA
6.89 REST OF APAC MARKET ANALYSIS BY EQUIPMENT TYPE
6.90 SOUTH AMERICA MARKET ANALYSIS
6.91 BRAZIL MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.92 BRAZIL MARKET ANALYSIS BY TESTING METHOD
6.93 BRAZIL MARKET ANALYSIS BY END USER
6.94 BRAZIL MARKET ANALYSIS BY APPLICATION AREA
6.95 BRAZIL MARKET ANALYSIS BY EQUIPMENT TYPE
6.96 MEXICO MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.97 MEXICO MARKET ANALYSIS BY TESTING METHOD
6.98 MEXICO MARKET ANALYSIS BY END USER
6.99 MEXICO MARKET ANALYSIS BY APPLICATION AREA
6.100 MEXICO MARKET ANALYSIS BY EQUIPMENT TYPE
6.101 ARGENTINA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.102 ARGENTINA MARKET ANALYSIS BY TESTING METHOD
6.103 ARGENTINA MARKET ANALYSIS BY END USER
6.104 ARGENTINA MARKET ANALYSIS BY APPLICATION AREA
6.105 ARGENTINA MARKET ANALYSIS BY EQUIPMENT TYPE
6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY TESTING METHOD
6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION AREA
6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY EQUIPMENT TYPE
6.111 MEA MARKET ANALYSIS
6.112 GCC COUNTRIES MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.113 GCC COUNTRIES MARKET ANALYSIS BY TESTING METHOD
6.114 GCC COUNTRIES MARKET ANALYSIS BY END USER
6.115 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION AREA
6.116 GCC COUNTRIES MARKET ANALYSIS BY EQUIPMENT TYPE
6.117 SOUTH AFRICA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.118 SOUTH AFRICA MARKET ANALYSIS BY TESTING METHOD
6.119 SOUTH AFRICA MARKET ANALYSIS BY END USER
6.120 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION AREA
6.121 SOUTH AFRICA MARKET ANALYSIS BY EQUIPMENT TYPE
6.122 REST OF MEA MARKET ANALYSIS BY GENOTYPING TECHNOLOGY
6.123 REST OF MEA MARKET ANALYSIS BY TESTING METHOD
6.124 REST OF MEA MARKET ANALYSIS BY END USER
6.125 REST OF MEA MARKET ANALYSIS BY APPLICATION AREA
6.126 REST OF MEA MARKET ANALYSIS BY EQUIPMENT TYPE
6.127 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
6.128 RESEARCH PROCESS OF MRFR
6.129 DRO ANALYSIS OF CHEMICALS AND MATERIALS
6.130 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
6.131 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
6.132 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
6.133 CHEMICALS AND MATERIALS, BY GENOTYPING TECHNOLOGY, 2024 (% SHARE)
6.134 CHEMICALS AND MATERIALS, BY GENOTYPING TECHNOLOGY, 2024 TO 2035 (USD Billion)
6.135 CHEMICALS AND MATERIALS, BY TESTING METHOD, 2024 (% SHARE)
6.136 CHEMICALS AND MATERIALS, BY TESTING METHOD, 2024 TO 2035 (USD Billion)
6.137 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
6.138 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Billion)
6.139 CHEMICALS AND MATERIALS, BY APPLICATION AREA, 2024 (% SHARE)
6.140 CHEMICALS AND MATERIALS, BY APPLICATION AREA, 2024 TO 2035 (USD Billion)
6.141 CHEMICALS AND MATERIALS, BY EQUIPMENT TYPE, 2024 (% SHARE)
6.142 CHEMICALS AND MATERIALS, BY EQUIPMENT TYPE, 2024 TO 2035 (USD Billion)
6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.2.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.2.3 BY END USER, 2025-2035 (USD Billion)
7.2.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.2.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.3.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.3.3 BY END USER, 2025-2035 (USD Billion)
7.3.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.3.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.4.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.4.3 BY END USER, 2025-2035 (USD Billion)
7.4.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.4.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.5.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.5.3 BY END USER, 2025-2035 (USD Billion)
7.5.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.5.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.6.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.6.3 BY END USER, 2025-2035 (USD Billion)
7.6.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.6.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.7.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.7.3 BY END USER, 2025-2035 (USD Billion)
7.7.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.7.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.8.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.8.3 BY END USER, 2025-2035 (USD Billion)
7.8.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.8.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.9.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.9.3 BY END USER, 2025-2035 (USD Billion)
7.9.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.9.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.10.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.10.3 BY END USER, 2025-2035 (USD Billion)
7.10.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.10.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.11.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.11.3 BY END USER, 2025-2035 (USD Billion)
7.11.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.11.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.12.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.12.3 BY END USER, 2025-2035 (USD Billion)
7.12.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.12.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.13.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.13.3 BY END USER, 2025-2035 (USD Billion)
7.13.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.13.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.14.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.14.3 BY END USER, 2025-2035 (USD Billion)
7.14.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.14.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.15.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.15.3 BY END USER, 2025-2035 (USD Billion)
7.15.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.15.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.16.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.16.3 BY END USER, 2025-2035 (USD Billion)
7.16.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.16.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.17.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.17.3 BY END USER, 2025-2035 (USD Billion)
7.17.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.17.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.18.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.18.3 BY END USER, 2025-2035 (USD Billion)
7.18.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.18.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.19.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.19.3 BY END USER, 2025-2035 (USD Billion)
7.19.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.19.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.20.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.20.3 BY END USER, 2025-2035 (USD Billion)
7.20.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.20.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.21.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.21.3 BY END USER, 2025-2035 (USD Billion)
7.21.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.21.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.22.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.22.3 BY END USER, 2025-2035 (USD Billion)
7.22.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.22.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.23.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.23.3 BY END USER, 2025-2035 (USD Billion)
7.23.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.23.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.24.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.24.3 BY END USER, 2025-2035 (USD Billion)
7.24.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.24.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.25.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.25.3 BY END USER, 2025-2035 (USD Billion)
7.25.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.25.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.26.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.26.3 BY END USER, 2025-2035 (USD Billion)
7.26.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.26.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.27.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.27.3 BY END USER, 2025-2035 (USD Billion)
7.27.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.27.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.28.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.28.3 BY END USER, 2025-2035 (USD Billion)
7.28.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.28.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.29.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.29.3 BY END USER, 2025-2035 (USD Billion)
7.29.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.29.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY GENOTYPING TECHNOLOGY, 2025-2035 (USD Billion)
7.30.2 BY TESTING METHOD, 2025-2035 (USD Billion)
7.30.3 BY END USER, 2025-2035 (USD Billion)
7.30.4 BY APPLICATION AREA, 2025-2035 (USD Billion)
7.30.5 BY EQUIPMENT TYPE, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Chemicals and Materials Market Segmentation

Chemicals and Materials By Genotyping Technology (USD Billion, 2025-2035)

SNP Genotyping
SSR Genotyping
Next-Generation Sequencing
DNA Microarrays

Chemicals and Materials By Testing Method (USD Billion, 2025-2035)

Destructive Testing
Non-Destructive Testing

Chemicals and Materials By End User (USD Billion, 2025-2035)

Research Institutions
Agricultural Biotechnology Companies
Government Agencies

Chemicals and Materials By Application Area (USD Billion, 2025-2035)

Plant Breeding
Disease Resistance
Genetic Diversity Analysis
Crop Improvement

Chemicals and Materials By Equipment Type (USD Billion, 2025-2035)

PCR Machines
Electrophoresis Equipment
Sequencing Systems
Sample Preparation Equipment

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓